| Literature DB >> 23616731 |
Abstract
Pregnant women and their unborn babies are excluded from most pharmaceutical research. We have to convince regulatory agencies worldwide that, by not demanding research of drug safety and effectiveness in pregnancy from pharmaceutical agencies, we are orphaning pregnant women from progress in therapeutics and causing both themselves and their unborn babies tremendous unacceptable risks.Entities:
Keywords: drugs; fetus; knowledge transfer; pregnancy; safety; toxicity
Year: 2013 PMID: 23616731 PMCID: PMC3626065 DOI: 10.5863/1551-6776-18.1.4
Source DB: PubMed Journal: J Pediatr Pharmacol Ther ISSN: 1551-6776